# 5630
For years battle lines have been drawn between agricultural interests and concerned scientists over the extensive and routine use of sub-therapeutic doses of antibiotics in farm animals.
Low levels of antibiotics – delivered to healthy herds via their water or feed – have been found to promote growth, lower production costs, and reduce animal mortality and morbidity on crowded factory farms.
Which makes them very popular among farmers.
But worried scientists point out that most of the antibiotics being used on the farm are functionally identical to those used in humans, and that their overuse (or misuse) can lead to the development of resistant organisms.
Late last year it was disclosed that roughly 80% of all antibiotics sold in the United States are used in agriculture (see Maryn McKenna’s Update: Farm Animals Get 80 Percent of Antibiotics Sold in U.S.).
The economic and public health stakes here are enormous, and so over the past few years we’ve seen a steady stream of conflicting statements and studies on the matter designed to influence the public, and regulators.
Despite a rising tide of resistant organisms being detected on the farm, the agricultural lobby maintains that scientific proof that the use of sub-therapeutic doses of antibiotics drives bacterial resistance is lacking.
Countering that position, today we’ve a new study appearing in the peer reviewed journal Microbial Drug Resistance that finds that low level exposures to three common antibiotics: amoxicillin, tetracycline, and enrofloxacin drives the acquisition of resistance in Escherichia coli.
First some excerpts from the press release, then a link to the study.
Mary Ann Liebert, Inc./Genetic Engineering News
E. coli bacteria more likely to develop resistance after exposure to low levels of antibiotics, reports a study in Microbial Drug Resistance
New Rochelle, NY, June 14, 2011—E. coli bacteria exposed to three common antibiotics were more likely to develop antibiotic resistance following low-level antibiotic exposure than after exposure to high concentrations that would kill the bacteria or inhibit their growth, according to a timely article in Microbial Drug Resistance, a peer-reviewed journal published by Mary Ann Liebert, Inc.
<SNIP>
Bacterial resistance to commonly prescribed antibiotics is an enormous and growing problem, largely due to misuse of antibiotics to treat non-bacterial infections and environmental exposure of the bacteria to low levels of antibiotics used, for example, in agriculture. In the article "De Novo Acquisition of Resistance to Three Antibiotics by Escherichia coli," the authors studied the mechanisms by which E. coli acquire resistance to three common antibiotics: amoxicillin, tetracycline, and enrofloxacin.
Depending on the antibiotic and the level of exposure, different mechanisms may come into play. The authors report that exposure to antibiotics at relatively low levels--below those needed to inhibit growth of the bacteria--are more likely to result in the development of antibiotic resistance. "Exposure to low levels of antibiotics therefore clearly poses most risk," a finding that "contradicts one of the main assumptions made questioning the threat of usage of antibiotics in food animals," conclude the authors.
The study (available as a PDF) is called:
De Novo Acquisition of Resistance to Three Antibiotics by Escherichia coli
Michael A. van der Horst,Jasper M. Schuurmans,
Marja C. Smid, Belinda B. Koenders, and Benno H. ter Kuile
For more on the legal wrangling surrounding the use of growth-promoting antibiotics in agriculture, I would direct you to Maryn McKenna’s Superbug Blog and her recent article:
Growth Promoters: If You Can’t Convince Them, Sue Them
- By Maryn McKenna
- May 25, 2011 |
Meanwhile - as scientists study, lobbyists lobby, and regulators contemplate their next move – nearly 80,000 pounds of antibiotics are used in this country every day on farm animals (28.8 million pounds/year).
Making regulation of the sane and sensible use of antibiotics on the farm desperately needed sooner rather than later.
Related Post:
- ECDC: Multidrug Resistant Infections Increasing In Europe
- CHP: Review Of NDM-1 In Hong Kong
- Referral: McKenna On Resistant Gonorrhea
- Study: Antimicrobial Prescribing Practices During The 2009 Pandemic
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- WHO: Urgent Action Needed On Resistant Gonorrhea
- Referral: McKenna Times Four
- HPA: Healthcare-Associated Infection (HCAI) Survey
- FDA Statement On Azithromycin & Cardiovascular Risks
- NEJM: Cardiovascular Risks Of Taking Azithromycin
- Video: Maryn McKenna On Antibiotic Resistance
- ECDC Comment On Drug Resistant TB In India
- Get Smart About Antibiotics Week
- CDDEP: Mapping Resistance
- NDM-1: One Year Later
- The Global Spread Of Drug Resistant Salmonella
- Study: Prior Antibiotic Use & MRSA In Children
- ECDC: Defining Bacterial Drug Resistance
- IDSA: Educational Guidelines Lower Antibiotic Use
- Going, Going, Gonorrhea
- The Path Of Increased Resistance
- Updating Hong Kong’s Scarlet Fever Outbreak
- When Old Bacteria Learns New Tricks
- UK: `New MRSA’ Strain Spreading
- CHP: Review Of NDM-1 In Hong Kong
- A Health Crisis In Slow Motion
- India: Still Looking For A Policy On Antibiotics
- Study: Antimicrobial Prescribing Practices During The 2009 Pandemic
- NDM-1: A Matter Of Import
- Referral: McKenna Times Four
- HPA: Healthcare-Associated Infection (HCAI) Survey
- Chan: World Faces A `Post-Antibiotic Era’
- WHO: The Evolving Threat Of Antimicrobial Resistance
- Get Smart About Antibiotics Week
- South African Statement On NDM-1 Cases
- India: The NDM-1 Story Continues
- India Puts Antibiotic Regulations On Hold
- CDDEP: Mapping Resistance
- NDM-1: One Year Later
- ECDC: Defining Bacterial Drug Resistance
- Netherlands: Large Nosocomial KPC Outbreak
- Going, Going, Gonorrhea
- The Path Of Increased Resistance
- Referral: McKenna On Drug Resistant E. Coli And Chickens
- More On Hong Kong's Scarlet Fever Outbreak
- When Old Bacteria Learns New Tricks
- UK: `New MRSA’ Strain Spreading
- India Looks For (And Finds) NDM-1
- CDC: Investigating Multi-State Outbreak Of Shiga-Toxin Producing E. coli
- E. Coli: In the Raw (cookie dough)
- ECDC: Lessons Learned On EHEC Outbreak
- EFSA Task Force Report On E. Coli O104:H4
- Sweden: First Domestic EHEC Case
- Referral: McKenna On Drug Resistant E. Coli And Chickens
- WHO: EHEC Update
- UK: Updated Sprout Safety Statement
- Referral: McKenna On E. Coli
- ECDC: EHEC/STEC Update June 13th
- RKI: Sprouts Behind Europe’s EHEC Outbreak
- A Double Referral: McKenna And Smith On EHEC
- EHEC: Preliminary Sprout Tests Negative
- Germany: Waiting For Test Results
- WHO Europe: EHEC Update & FAQ
- CDC Health Advisory (HAN) On Shiga-Toxin Producing E. Coli 0104
- Report: EHEC Outbreak From New E. Coli Strain
- CDC Statement On Europe’s EHEC (STEC) Outbreak
- Cucumbers Linked To German E. Coli Outbreak
- E. Coli & Hemolytic Uremic Syndrome In Germany
- Hold The Lettuce
Widget by [ Iptek-4u ]